NHP2 deficiency impairs rRNA biogenesis and causes pulmonary fibrosis and Høyeraal-Hreidarsson syndrome.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
15 04 2020
Historique:
received: 03 07 2019
revised: 14 01 2020
accepted: 17 01 2020
pubmed: 28 1 2020
medline: 6 7 2021
entrez: 28 1 2020
Statut: ppublish

Résumé

Telomeres are nucleoprotein structures at the end of chromosomes. The telomerase complex, constituted of the catalytic subunit TERT, the RNA matrix hTR and several cofactors, including the H/ACA box ribonucleoproteins Dyskerin, NOP10, GAR1, NAF1 and NHP2, regulates telomere length. In humans, inherited defects in telomere length maintenance are responsible for a wide spectrum of clinical premature aging manifestations including pulmonary fibrosis (PF), dyskeratosis congenita (DC), bone marrow failure and predisposition to cancer. NHP2 mutations have been so far reported only in two patients with DC. Here, we report the first case of Høyeraal-Hreidarsson syndrome, the severe form of DC, caused by biallelic missense mutations in NHP2. Additionally, we identified three unrelated patients with PF carrying NHP2 heterozygous mutations. Strikingly, one of these patients acquired a somatic mutation in the promoter of TERT that likely conferred a selective advantage in a subset of blood cells. Finally, we demonstrate that a functional deficit of human NHP2 affects ribosomal RNA biogenesis. Together, our results broaden the functional consequences and clinical spectrum of NHP2 deficiency.

Identifiants

pubmed: 31985013
pii: 5715904
doi: 10.1093/hmg/ddaa011
doi:

Substances chimiques

NHP2 protein, human 0
Nuclear Proteins 0
RNA, Ribosomal 0
Ribonucleoproteins, Small Nuclear 0
TERT protein, human EC 2.7.7.49
Telomerase EC 2.7.7.49

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

907-922

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Maname Benyelles (M)

INSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée La Ligue contre le Cancer, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.

Marie-Françoise O'Donohue (MF)

Laboratoire de Biologie Moléculaire Eucaryote, Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Laëtitia Kermasson (L)

INSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée La Ligue contre le Cancer, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.

Elodie Lainey (E)

Hematology Laboratory, Robert DEBRE Hospital-APHP and INSERM UMR 1131-Hematology University Institute-Denis Diderot School of Medicine, Paris, France.

Raphael Borie (R)

APHP, Hôpital Bichat, Service de Pneumologie A, DHU FIRE, Paris, France.
INSERM, Unité 1152, Paris, France.
Université Paris Diderot, Paris, France.

Chantal Lagresle-Peyrou (C)

Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France.
University of Paris Descartes-Sorbonne Paris Cité, Paris, France.

Hilario Nunes (H)

Service de Pneumologie, Centre de Référence des Maladies Pulmonaires rares, Hôpital Avicenne, AP-HP, INSERM 1272, Université Paris 13, Bobigny, France.

Clarisse Cazelles (C)

Service d'hématologie adulte, Hôpital Necker- Enfants malades, Paris, France.

Cécile Fourrage (C)

INSERM UMR 1163, Genomics platform, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Genomic Core Facility, Imagine Institute-Structure Fédérative de Recherche Necker, INSERM U1163, Paris, France.

Emmanuelle Ollivier (E)

INSERM UMR 1163, Genomics platform, Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.
Genomic Core Facility, Imagine Institute-Structure Fédérative de Recherche Necker, INSERM U1163, Paris, France.

Ambroise Marcais (A)

Service d'hématologie Adultes, Hôpital Necker-Enfants Malades, Assistance publique hôpitaux de Paris, Paris, France, Laboratoire d'onco-hématologie, Institut Necker-Enfants Malades, INSERM U1151, Université Paris Descartes, Paris, France.

Anne-Sophie Gamez (AS)

Service de Montpellier, CHU Montpellier, Montpellier, France.

Fanny Morice-Picard (F)

Service de Dermatologie Pédiatrique, Centre de Reference des Maladies Rares de la Peau, CHU de Bordeaux, Bordeaux F-33076, France.

Denis Caillaud (D)

Service de Pneumologie-Allergologie, Hôpital Gabriel Montpied, Université Clermont Auvergne, Clermont-Ferrand, France.

Nicolas Pottier (N)

Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA4483-IMPECS, Lille, France.

Christelle Ménard (C)

APHP Service de Génétique, Hôpital Bichat, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Ibrahima Ba (I)

APHP Service de Génétique, Hôpital Bichat, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Alicia Fernandes (A)

Biological Resources Center, Structure Fédérative de Recherche Necker, INSERM US24, CNRS UMS3633, Assistance Publique des Hôpitaux de Paris and Institut Imagine, Paris, France.

Bruno Crestani (B)

APHP, Hôpital Bichat, Service de Pneumologie A, DHU FIRE, Paris, France.

Jean-Pierre de Villartay (JP)

INSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée La Ligue contre le Cancer, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.

Pierre-Emmanuel Gleizes (PE)

Laboratoire de Biologie Moléculaire Eucaryote, Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Isabelle Callebaut (I)

Sorbonne Université, Muséum National d'Histoire Naturelle, UMR CNRS 7590, Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie, IMPMC, 75005 Paris, France.

Caroline Kannengiesser (C)

APHP Service de Génétique, Hôpital Bichat, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Patrick Revy (P)

INSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée La Ligue contre le Cancer, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH